Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,754 evidence items · page 19 / 71

4 %The prevalence of the 60E substitution in protease sequences was 4% among 57 HIV-1-infected treatment-naive individuals from Cameroon.

CamerounVIH/sidapublished 2011AIDS Research and Human RetrovirusesOpenAlexdocument of 24 observations

331,000,000 inhabitantsThe number of people aged 30–79 years with hypertension doubled from 1990 to 2019, from 331 million women and 317 million men in 1990 to 626 million women and 652 million men in 2019.

Camerounhypertension artérielleobserved 1990published 2021Lancet (London, England)europe_pmcdocument of 8 observations

71.7 %The prevalence of metabolic syndrome was 71.7% according to the International Diabetes Federation criteria in a group of Cameroonians with type 2 diabetes.

Cameroundiabète de type 2 · syndrome métaboliquepublished 2012Diabetology & metabolic syndromeeurope_pmcdocument of 4 observationsDOI 10.1186/1758-5996-4-22

162 countriesFrom 1990 to 2022, the combined prevalence of underweight and obesity in adults increased in 162 countries (81%) for women and 140 countries (70%) for men with a posterior probability of at least 0.80.

Cameroununderweight and obesityobserved 1990 to 2022published 2024Lancet (London, England)europe_pmcdocument of 9 observations

12 %Klebsiella pneumonia accounted for 12% of isolated germs.

Camerounpied diabétiquepublished 2022The Pan African medical journaleurope_pmcdocument of 25 observations

16.1 %The leading three causes of disability-adjusted life-years (DALYs) globally were ischaemic heart disease, cerebrovascular disease, and lower respiratory infections, comprising 16.1% of all DALYs.

Camerouncerebrovascular disease · ischaemic heart disease · lower respiratory infectionspublished 2017Lancet (London, England)europe_pmcdocument of 7 observations

1.8 %The age-standardized prevalence of impaired glucose tolerance in the urban population of Cameroon was 1.8% for men.

Camerounimpaired glucose tolerancepublished 1997Diabetologiaeurope_pmcdocument of 12 observationsDOI 10.1007/s001250050755

21 %The overall HCV seroprevalence rate in the study population was 21.0% (95% CI 17.4%–24.9%).

Camerounhépatite Cobserved 2001published 2007Emerging infectious diseasesOpenAlexdocument of 7 observationsDOI 10.3201/eid1303.061069

3.6 odds_ratioThe summary odds ratio between non-autoimmune diabetes and HCV infection risk was 3.6 (95% CI: 2.7–4.9) based on 43 studies.

Camerounhépatite C · non-autoimmune diabetes mellituspublished 2021Scientific reportseurope_pmcdocument of 11 observationsDOI 10.1038/s41598-021-88598-6

7 %Diabetes prevalence in upper-middle income countries in the Africa Region (AFR) was 7.0%.

Cameroundiabète (non précisé)published 2014Diabetes research and clinical practiceeurope_pmcdocument of 14 observations

Diastolic blood pressure was significantly increased with duration of highly active antiretroviral therapy (HAART) in HIV-infected Cameroonians.

CamerounVIH/sidapublished 2013Diabetes & metabolismeurope_pmcdocument of 12 observations

4.2 yearsThe mean duration of diabetes was 4.2 ± 2.8 years in Cameroonian adolescents with type 1 diabetes mellitus.

Cameroundiabète de type 1published 2017World journal of diabeteseurope_pmcdocument of 9 observations

28,400,000 DALYsIn 2017, tracheal, bronchus, and lung cancer caused 28.4 million DALYs in men.

Camerountracheal, bronchus, and lung cancerobserved 2017published 2019JAMA oncologyeurope_pmcdocument of 25 observationsDOI 10.1001/jamaoncol.2019.2996

5 %Across the surveys, the median prevalence of diabetes was 5%.

Cameroundiabète (non précisé)observed 2005-15published 2016The lancet. Diabetes & endocrinologyeurope_pmcdocument of 10 observations

49 samplesAmong 747 serum samples collected from humans in rural village areas in Cameroon, 49 samples were confirmed to be HTLV type I by Western blot assay.

CamerounHTLV type Ipublished 2005Clinical Infectious DiseasesOpenAlexdocument of 2 observationsDOI 10.1086/429910

3.95 %In monkeys from Cameroon, the highest IgG prevalence were observed against ONNV-E2 with 3.95% and DENV2-NS1 with 3.40%.

Cameroundengue virus serotype 2 · O'nyong-nyong viruspublished 2021PLoS neglected tropical diseasesOpenAlexdocument of 8 observationsDOI 10.1371/journal.pntd.0009028

18.3 %The risk of ischemic stroke was 18.3%.

CamerounAVCobserved 2016published 2018The New England journal of medicineeurope_pmcdocument of 12 observations

2.508 odds_ratioPatients self-managing (monitoring glucose levels and adjusting insulin accordingly) had an odds ratio of 2.508 (95% CI: 1.500–4.191) for achieving HbA1c <7%.

Cameroundiabète de type 1published 2020Medicineeurope_pmcdocument of 9 observations

76 %In ketosis-prone type 2 diabetes, discontinuation of insulin therapy with development of remission of insulin dependence is achieved in 76% of patients.

Cameroundiabète de type 2published 2004Diabeteseurope_pmcdocument of 8 observationsDOI 10.2337/diabetes.53.3.645

2 %Plasmodium ovale was identified in 2% (17/791) of samples in Tibati.

CamerounpaludismeHAL · Unilimdocument of 106 observations

9.3 %Baseline HbA1c was 9.3 ± 1.3% in the study population.

Cameroundiabète de type 2published 2018BMC oral healtheurope_pmcdocument of 6 observations

27 %In 2019, 27.0% of all adolescent deaths were due to non-communicable diseases.

Camerounmaladies non transmissiblesobserved 2019published 2021Lancet (London, England)europe_pmcdocument of 13 observations

14.8 %Global age-standardised prevalence of moderate and severe underweight in boys decreased from 14.8% in 1975 to 12.4% in 2016.

Camerounmalnutritionobserved 1975published 2017Lancet (London, England)europe_pmcdocument of 12 observations

Hypoglycaemia was treated with intravenous (10%) glucose in diabetic coma patients at Yaounde Central Hospital.

Camerounhypoglycaemiaobserved November 1999 to October 2002published 2008Annals of tropical medicine and parasitologyeurope_pmcdocument of 12 observationsDOI 10.1179/136485908x252188

50,000,000 individualsIn 2016, 50 million girls worldwide were obese.

Camerounobésitéobserved 2016published 2017Lancet (London, England)europe_pmcdocument of 12 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.